Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Amgen Inc. (AMGN $347.07)
- $347.07 P/E (TTM): 26.53X Cap: $186.89B
- View AMGN Profile
- View Questions on AMGN
-
Cerner Corporation (CERN)
- P/E (TTM): 46.72X
- View CERN Profile
- View Questions on CERN
-
AbbVie Inc. (ABBV $218.11)
- $218.11 P/E (TTM): 165.0X Cap: $385.48B
- View ABBV Profile
- View Questions on ABBV
-
Merck & Company Inc. (MRK $109.18)
- $109.18 P/E (TTM): 14.69X Cap: $270.98B
- View MRK Profile
- View Questions on MRK
-
Pfizer Inc. (PFE $25.67)
- $25.67 P/E (TTM): 15.05X Cap: $148.39B
- View PFE Profile
- View Questions on PFE
-
Teladoc Health Inc. (TDOC $6.35)
- $6.35 Cap: $1.12B
- View TDOC Profile
- View Questions on TDOC
-
WELL Health Technologies Corp. (WELL $4.20)
- $4.20 Cap: $1.06B
- View WELL Profile
- View Questions on WELL
- View Reports on WELL
-
Change Healthcare Inc. (CHNG)
Q: In your response to Marco's question on March 11 you mentioned you felt there were better opportunities in the US. Could you mention your top choices. Thank you.
-
Change Healthcare Inc. (CHNG)
-
Health Catalyst Inc (HCAT $2.36)
- $2.36 Cap: $166M
- View HCAT Profile
- View Questions on HCAT
Q: Hello there,
Any views on CHNG ? Good for a growth portfolio ? Anything better in that sector ?
Reply at your leisure. No rush.
Season's greetings to all of you,
Jacques IDS
Any views on CHNG ? Good for a growth portfolio ? Anything better in that sector ?
Reply at your leisure. No rush.
Season's greetings to all of you,
Jacques IDS
Insiders
Share Information
SEC Filings
News and Media